Levosimendan in Regional Myocardial Ischemia


Levosimendan is a new positive inotropic agent with anxillary vasodilating effects. It increases heart rate, stroke volume, and cardiac output and decreases systemic, pulmonary and coronary artery vascular resistance as well as filling pressures [1]. Its mode of action is believed to involve a unique calcium sensitizing effect: it binds to Troponin C in a… (More)
DOI: 10.1023/A:1022199932485


  • Presentations referencing similar topics